Charles R. Kummeth
Charles R. Kummeth's purchase track record
Charles R. Kummeth has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/5/2026 | QSI | $460K | +40.7% | -16.4% | +13.4% |
| 8/9/2024 | QSI | $148K | +6.0% | +130.0% | +12.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Gentherm Announces Q3 2026 Release Date and Special Dividend. Gentherm has scheduled the date for its 2026 third‑quarter news release and the accompanying conference call. The company also announced a special dividend and made changes to its board of directors, which could reflect a shift in strategic focus. Both items were disclosed in recent filings and press releases.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
QSI impacted by regional tensions in Gulf markets. Saudi and Gulf stocks recently declined after the Houthis claimed attacks on Riyadh. This regional instability may affect sentiment for Quantum-Si Incorporated, which operates in the Middle East. The stock is currently trading within its 52-week range, with technical indicators showing a breakout signal.
Transaction History
| OFIX | ▲ Buy | Grant | 14,965 | $0 | 6/10/2026 | View on chart |
| THRM | ▲ Buy | Grant | 4,292 | $0 | 5/14/2026 | View on chart |
| QSI | ▲ Buy | Open Market | 500,000 | $460K | 3/5/2026 | View on chart |
| OFIX | ▲ Buy | Grant | 18,841 | $0 | 6/18/2025 | View on chart |
| THRM | ▲ Buy | Grant | 5,075 | $0 | 5/8/2025 | View on chart |
| QSI | ▲ Buy | Open Market | 31,100 | $28K | 8/12/2024 | View on chart |
| QSI | ▲ Buy | Open Market | 138,900 | $121K | 8/9/2024 | View on chart |
| OFIX | ▲ Buy | Grant | 15,152 | $195K | 6/18/2024 | View on chart |
| THRM | ▲ Buy | Grant | 2,662 | $0 | 5/16/2024 | View on chart |
| OFIX | ▲ Buy | Grant | 8,350 | $116K | 1/31/2024 | View on chart |
| THRM | ▲ Buy | Grant | 2,147 | $0 | 5/18/2023 | View on chart |
| THRM | ▲ Buy | Grant | 1,700 | $0 | 6/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Orthofix pays $24M in damages to former executives
Orthofix Medical has paid $24 million in damages to former executives. This significant cash outflow may impact the company's financial position. The stock currently trades near its 52-week low, with analysts averaging a $13 target price.
Orthofix pays $24M in damages to former executives. Orthofix Medical has paid $24 million in damages to former executives. This significant cash outflow may impact the company's financial position. The stock currently trades near its 52-week low, with analysts averaging a $13 target price.